Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

644 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen HU, Riedel O, Dodel R. Kalbe E, et al. Among authors: witt k. J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1099-105. doi: 10.1136/jnnp-2016-313838. Epub 2016 Jul 8. J Neurol Neurosurg Psychiatry. 2016. PMID: 27401782
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G. Witt K, et al. Lancet Neurol. 2008 Jul;7(7):605-14. doi: 10.1016/S1474-4422(08)70114-5. Epub 2008 Jun 4. Lancet Neurol. 2008. PMID: 18538636 Clinical Trial.
Subthreshold depression in Parkinson's disease.
Reiff J, Schmidt N, Riebe B, Breternitz R, Aldenhoff J, Deuschl G, Witt K. Reiff J, et al. Among authors: witt k. Mov Disord. 2011 Aug 1;26(9):1741-4. doi: 10.1002/mds.23699. Epub 2011 Mar 25. Mov Disord. 2011. PMID: 21442660
Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
Witt K, Daniels C, Krack P, Volkmann J, Pinsker MO, Kloss M, Tronnier V, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G. Witt K, et al. J Neurol Sci. 2011 Nov 15;310(1-2):261-6. doi: 10.1016/j.jns.2011.06.028. Epub 2011 Jul 5. J Neurol Sci. 2011. PMID: 21733529 Clinical Trial.
Parkinson's disease and dementia: a longitudinal study (DEMPARK).
Balzer-Geldsetzer M, Costa AS, Kronenbürger M, Schulz JB, Röske S, Spottke A, Wüllner U, Klockgether T, Storch A, Schneider C, Riedel O, Wittchen HU, Seifried C, Hilker R, Schmidt N, Witt K, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Gräber-Sultan S, Berg D, Gasser T, Kalbe E, Bodden M, Oertel WH, Dodel R. Balzer-Geldsetzer M, et al. Among authors: witt k. Neuroepidemiology. 2011;37(3-4):168-76. doi: 10.1159/000331490. Epub 2011 Nov 4. Neuroepidemiology. 2011. PMID: 22067139
Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
Daniels C, Krack P, Volkmann J, Raethjen J, Pinsker MO, Kloss M, Tronnier V, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G, Witt K. Daniels C, et al. Among authors: witt k. Mov Disord. 2011 Dec;26(14):2516-21. doi: 10.1002/mds.23907. Epub 2011 Aug 25. Mov Disord. 2011. PMID: 22170276 Clinical Trial.
644 results